Industry News

• Marker Therapeutics reports interim results of MultiTAA T cell therapy in patients  Marker Therapeutics announced interim data from an ongoing investigator-sponsored clinical trial led by Baylor College of Medicine, evaluating the Company’s MultiTAA T cell therapy in patients with pancreatic adenocarcinoma.
  July 20, 2019  
• NIH study links air pollution to increase in newborn intensive care admissions  Infants born to women exposed to high levels of air pollution in the week before delivery are more likely to be admitted to a newborn intensive care unit, suggests an analysis by researchers at the NIH. Chances for NICU admission increased from about 4% to as much as 147%.
  July 19, 2019  
• NIH publishes largest genomic study on type 2 diabetes in sub-Saharan African population  NIH researchers reported the largest genomic study of type 2 diabetes in sub-Saharan Africans, with data from more than 5,000 individuals from Nigeria, Ghana and Kenya. Researchers identified a novel gene ZRANB3, which may influence susceptibility to the disease in sub-Saharan African populations.
  July 19, 2019  
• Space research helps patients on Earth with low blood pressure condition  With the 50th anniversary of the Apollo 11 moon landing approaching, UT Southwestern Medical Center researchers are publishing heart-related space research that helps us to understand the problem of low blood pressure.
  July 19, 2019  
• FDA accepts and files 22nd Century Group’s modified risk tobacco product application  22nd Century announced the FDA accepted and filed for substantive scientific review the Company’s Modified Risk Tobacco Product application for its exclusive Very Low Nicotine Content cigarettes under the proposed brand name of VLNTM.
  July 19, 2019  
• U of A researcher uses canola to create biodegradable cling wrap   A University of Alberta researcher has found a new use for a canola byproduct and using its oil—is proving useful in strengthening a plant-based cling wrap. The research team used cellulose nanofibres from canola straw to make the clear, plastic-like film.
  July 19, 2019  Bev Betkowski
• Researchers publish new study on citrus greening disease  A new study published by researchers at Virginia Tech with a team of international researchers in Journal of Applied Ecology investigates the thermal suitability for transmission of citrus greening with implications for surveillance and prevention.
  July 19, 2019  
• ADL Bionatur Solutions and Amyris expand contract to 2020  ADL Bionatur Solutions announces the expansion of its existing production agreement with Amyris. ADL will produce up to five ingredients for Amyris during the contracted period with the contract revenues amounting to at least EUR 12 million and an extension option for future years.
  July 19, 2019  
• Amgen and Allergan's MVASI™ and KANJINTI™ now available in the U.S.  Amgen and Allerga announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab), are now available in the U.S.
  July 19, 2019  
• Amarin prices public offering of American Depositary Shares  Amarin announced pricing of the underwritten public offering of 22,222,223 American Depositary Shares at a price to the public of $18.00 per ADS. The gross proceeds of this offering are expected to be approximately $400.0 million. The offering is expected to close July 23, 2019.
  July 19, 2019  

   (next 10 articles)